More recent data [47] obtained by dot-blotting and immunofluorescence indicated that, consistent with the down-regulation of B3GALT5, the CA19.9 antigen was almost undetectable in colon cancer. This evidence concerns the gene B3GALT5 and malignant colon neoplasm.